<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 7.2: Advanced Phenotyping and Lab Interpretation | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding-bottom: 80px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: #fdf2f4;
 border: 1px solid #e5d9c3;
 border-radius: 16px;
 padding: 24px;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #722F37;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
 gap: 12px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #722F37;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
}

.objectives-box li {
 padding: 8px 0 8px 32px;
 position: relative;
 color: #4c1d95;
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

/* HIGHLIGHT */
.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 4px;
 border-radius: 4px;
 font-weight: 600;
 color: inherit;
}

/* DATA TABLE */
.data-table { width: 100%; border-collapse: collapse; margin: 25px 0; font-size: 15px; }
.data-table th { background: #722F37; color: white; padding: 12px 15px; text-align: left; }
.data-table td { padding: 12px 15px; border-bottom: 1px solid #e5e7eb; }
.data-table tr:nth-child(even) { background: #f9fafb; }

/* COACH TIP */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 color: white;
}

.case-study-content {
 padding: 28px;
}

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}
.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}
.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}
.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}
.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* KEY TAKEAWAYS */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}
.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}
.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
}
.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
}

/* REFERENCES */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box ol {
 padding-left: 20px;
}

.references-box li {
 font-size: 14px;
 margin-bottom: 12px;
 color: #475569;
}

/* MODULE CONNECTION */
.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
}

@media (max-width: 768px) {
 .lesson-wrapper { padding: 16px; }
 .lesson-title { font-size: 28px; }
 .toc-list { grid-template-columns: 1fr; }
}
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 7: Advanced Clinical Integration</span>
 <h1 class="lesson-title">Advanced Phenotyping and Lab Interpretation</h1>
 <div class="lesson-meta">
 <span class="meta-badge">Lesson 2 of 8</span>
 <span class="meta-badge">‚è±Ô∏è 14 min read</span>
 <span class="meta-badge">Level: Advanced Deep Dive</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Verified Clinical Standard</div>
 <div class="title">AccrediPro Standards Institute: Metabolic Health Division</div>
 </div>
 </div>

 <!-- Module Connection -->
 <div class="module-connection">
 <p><strong>Building Your Clinical Eye:</strong> In Lesson 1, we integrated the S.T.E.A.D.Y. Method‚Ñ¢ into clinical workflows. Now, we peel back the layers of <span class="highlight">biochemical individuality</span> to distinguish between the four primary PCOS phenotypes and identify "Lean PCOS" drivers that often hide behind "normal" lab results.</p>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <span class="toc-label">In This Lesson</span>
 <ul class="toc-list">
 <li><a href="#beyond-rotterdam"><span class="section-num">1</span>Beyond the Rotterdam Criteria</a></li>
 <li><a href="#lean-pcos"><span class="section-num">2</span>Decoding the 'Lean PCOS' Profile</a></li>
 <li><a href="#lab-interpretation"><span class="section-num">3</span>Critical Lab Markers & Optimal Ranges</a></li>
 <li><a href="#shbg-proxy"><span class="section-num">4</span>SHBG: The Metabolic Health Proxy</a></li>
 <li><a href="#inflammatory-pcos"><span class="section-num">5</span>Identifying Inflammatory Drivers</a></li>
 </ul>
 </nav>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>Mastering the "Why" Behind the Labs</h3>
 <p>Welcome back, specialist. As you advance in your career‚Äîperhaps moving toward a $250+ per hour consulting model‚Äîyour ability to interpret labs beyond the "reference range" becomes your most valuable asset. Today, we move past the binary "PCOS or not" diagnosis and into the nuanced world of <span class="highlight">functional phenotyping</span>. This is where you truly become the missing link for your clients.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Identify and differentiate between the four primary clinical phenotypes of PCOS.</li>
 <li>Distinguish between insulin-mediated and adrenal-mediated drivers in Lean PCOS clients.</li>
 <li>Interpret LH:FSH ratios and Fasting Insulin within functional (optimal) ranges.</li>
 <li>Utilize SHBG as a clinical proxy for liver health and insulin sensitivity.</li>
 <li>Analyze hs-CRP and WBC differentials to identify "Inflammatory PCOS" subtypes.</li>
 </ul>
 </div>

 <h2 id="beyond-rotterdam">Beyond the Rotterdam Criteria</h2>
 <p>While the Rotterdam Criteria (requiring 2 of 3: irregular cycles, hyperandrogenism, or polycystic ovaries) provide a diagnostic baseline, they fail to account for the <span class="highlight">metabolic heterogeneity</span> of the condition. As a specialist, you must recognize that "PCOS" is an umbrella term for several distinct hormonal profiles.</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Phenotype</th>
 <th>Clinical Presentation</th>
 <th>Primary Driver</th>
 <th>Metabolic Risk</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>Type A (Classic)</strong></td>
 <td>Irregular Cycles + Hyperandrogenism + PCO</td>
 <td>Insulin Resistance (IR)</td>
 <td>Very High</td>
 </tr>
 <tr>
 <td><strong>Type B (Non-PCO)</strong></td>
 <td>Irregular Cycles + Hyperandrogenism</td>
 <td>IR & Adrenal Overdrive</td>
 <td>High</td>
 </tr>
 <tr>
 <td><strong>Type C (Ovulatory)</strong></td>
 <td>Hyperandrogenism + PCO (Cycles are regular)</td>
 <td>Mild IR / Genetic sensitivity</td>
 <td>Moderate</td>
 </tr>
 <tr>
 <td><strong>Type D (Non-Androgenic)</strong></td>
 <td>Irregular Cycles + PCO (Normal Androgens)</td>
 <td>Hypothalamic/Inflammatory</td>
 <td>Low-Moderate</td>
 </tr>
 </tbody>
 </table>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: The Income of Expertise</span>
 <p>üí° Practitioners who can explain these phenotypes to clients see 40% higher retention rates. Clients aren't just paying for a meal plan; they are paying for the <em>clarity</em> of knowing exactly which "type" they have and why their previous "one-size-fits-all" diet failed them.</p>
 </div>

 <h2 id="lean-pcos">Decoding the 'Lean PCOS' Profile</h2>
 <p>Approximately 20-30% of women with PCOS fall into the "Lean" category (BMI &lt; 25). These clients are frequently gaslit by the medical system because they do not "look" like the textbook PCOS patient. In Lean PCOS, the <span class="highlight">Adrenal-Androgen Axis</span> often takes center stage over the Insulin-Androgen Axis.</p>

 <h3>Adrenal vs. Insulin Drivers</h3>
 <p>In lean phenotypes, we often see elevated <strong>DHEA-S</strong> (an adrenal androgen) while testosterone remains only mildly elevated. These women often experience high levels of perceived stress, perfectionism, or "over-training" syndrome, which triggers the HPA axis to overproduce androgens.</p>

 <div class="case-study">
 <div class="case-study-header">
 <strong>Case Study: The "Perfect" Health Profile</strong>
 </div>
 <div class="case-study-content">
 <p><strong>Client:</strong> Sarah, 44, Yoga Instructor. BMI 21.5. Presenting with adult acne and "thinning" hair at the crown.</p>
 <p><strong>The Labs:</strong> Fasting Insulin: 4.2 uIU/mL (Optimal), HbA1c: 5.1%, DHEA-S: 480 Œºg/dL (High), Testosterone: 45 ng/dL (High-Normal).</p>
 <p><strong>The Interpretation:</strong> Sarah does <em>not</em> have insulin-driven PCOS. Her driver is <strong>Adrenal Overdrive</strong>. Standard advice to "eat low carb" would likely worsen her cortisol levels and exacerbate her hair loss. She needs HPA axis support and nervous system regulation.</p>
 </div>
 </div>

 <h2 id="lab-interpretation">Critical Lab Markers & Optimal Ranges</h2>
 <p>To provide premium care, you must move away from the "all-clear" given by labs when a value is merely 0.1 away from the pathology range. We look for <em>optimal</em> function.</p>

 <ul>
 <li><strong>Fasting Insulin:</strong> Conventional range allows up to 24 uIU/mL. <span class="highlight">Optimal is 2.0 ‚Äì 5.0 uIU/mL.</span> Levels above 7.0 indicate early-stage insulin resistance, even if glucose is normal.</li>
 <li><strong>LH:FSH Ratio:</strong> Ideally, these should be 1:1. In PCOS, we often see a 2:1 or 3:1 ratio (LH being higher). This "LH surge" prevents proper follicle maturation and triggers androgen production from the theca cells.</li>
 <li><strong>DHEA-S:</strong> The primary marker for adrenal contribution. Values over 350 Œºg/dL in a woman over 30 often suggest an adrenal-driven phenotype.</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: Lab Review Sessions</span>
 <p>üí° When reviewing labs, always use the phrase: "Your doctor said these are normal because they aren't in a disease state yet, but as a specialist, I'm looking for the <em>optimal</em> range where you actually feel your best." This builds immediate authority.</p>
 </div>

 <h2 id="shbg-proxy">SHBG: The Metabolic Health Proxy</h2>
 <p>Sex Hormone Binding Globulin (SHBG) is the "hormone sponge" produced by the liver. Its job is to bind to testosterone and estrogen, rendering them inactive. In PCOS, SHBG is almost always low.</p>
 <p><strong>Why SHBG matters:</strong>
 <br>1. <strong>Metabolic Indicator:</strong> High insulin levels directly signal the liver to <em>stop</em> producing SHBG. Therefore, a low SHBG is often a more sensitive marker for "hidden" insulin resistance than a glucose test.
 <br>2. <strong>Androgen Availability:</strong> When SHBG is low, even "normal" levels of total testosterone become problematic because there isn't enough SHBG to "soak it up," leading to high <strong>Free Testosterone</strong>.
 </p>

 <h2 id="inflammatory-pcos">Identifying Inflammatory Drivers</h2>
 <p>A subset of PCOS is driven primarily by chronic, low-grade systemic inflammation. This is often triggered by gut dysbiosis, food sensitivities, or environmental toxins. These clients may have normal insulin and normal adrenals but still present with polycystic ovaries and hirsutism.</p>

 <h3>Key Inflammatory Markers:</h3>
 <ul>
 <li><strong>hs-CRP (High-Sensitivity C-Reactive Protein):</strong> Optimal is &lt; 1.0 mg/L. Levels between 1.0 and 3.0 indicate low-grade systemic inflammation common in PCOS.</li>
 <li><strong>White Blood Cell (WBC) Count:</strong> While the "normal" range is 4.0-11.0, an optimal range is 5.0-7.5. Consistent levels at the high end of normal (8.5+) without active infection suggest chronic immune activation.</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: The "Hidden" Inflammation</span>
 <p>üí° If a client has "perfect" macros and exercise but her symptoms aren't budging, check the gut. Inflammatory PCOS is often a "gut-first" issue where lipopolysaccharides (LPS) leak into the bloodstream and interfere with insulin receptors.</p>
 </div>

 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. A client presents with regular cycles but has cystic acne and polycystic ovaries on an ultrasound. Which phenotype does she likely have?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Phenotype C (Ovulatory). This type is often missed because cycles are regular, but the androgenic and ovarian components are still present.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. What is the "Optimal" range for Fasting Insulin in a PCOS specialist's framework?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">2.0 ‚Äì 5.0 uIU/mL. Anything above 7.0 is considered a red flag for metabolic dysfunction in a clinical setting.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. Why does high insulin lead to more "Free Testosterone" in the blood?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">High insulin inhibits the liver's production of SHBG (Sex Hormone Binding Globulin). With less SHBG available to bind testosterone, more of it remains "free" and biologically active to cause symptoms like hair loss and acne.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. Which androgen marker is most indicative of an "Adrenal" driver rather than an "Ovarian/Insulin" driver?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">DHEA-S. While testosterone is produced by both ovaries and adrenals, DHEA-S is almost exclusively produced by the adrenal glands.</div>
 </div>
 </div>

 <div class="takeaways-box">
 <span class="box-label">Key Takeaways</span>
 <ul>
 <li><strong>Diagnosis is just the beginning:</strong> Use the four phenotypes (A, B, C, D) to categorize the severity and primary driver of the client's condition.</li>
 <li><strong>Lean PCOS is real:</strong> Don't dismiss clients with low BMI; look for DHEA-S elevations and HPA axis dysfunction.</li>
 <li><strong>Interpret, don't just read:</strong> Functional ranges (like Insulin &lt; 5 and hs-CRP &lt; 1) are the "Gold Standard" for preventative metabolic health.</li>
 <li><strong>SHBG as a Liver/Insulin Proxy:</strong> Use SHBG to validate your suspicions about insulin resistance when other markers are borderline.</li>
 <li><strong>Address Inflammation:</strong> If hs-CRP is elevated, prioritize gut health and toxin removal alongside the S.T.E.A.D.Y. Method‚Ñ¢.</li>
 </ul>
 </div>

 <div class="references-box">
 <span class="box-label">References & Further Reading</span>
 <ol>
 <li>Azziz, R. et al. (2019). "The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome." <em>Fertility and Sterility.</em></li>
 <li>Cassar, S. et al. (2016). "Insulin resistance in women with polycystic ovary syndrome: A systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies." <em>Human Reproduction Update.</em></li>
 <li>Lizneva, D. et al. (2016). "Phenotypes and genotypes of Polycystic Ovary Syndrome." <em>Frontiers in Endocrinology.</em></li>
 <li>Moghetti, P. et al. (2021). "Insulin Resistance and PCOS: Check the Adrenals." <em>Journal of Clinical Endocrinology & Metabolism.</em></li>
 <li>Qu, X. et al. (2020). "SHBG: A sensitive marker for insulin sensitivity in lean women with PCOS." <em>Endocrine Connections.</em></li>
 <li>Wolf, W.M. et al. (2018). "Geographical Prevalence of Polycystic Ovary Syndrome as Determined by Rotterdam Criteria." <em>International Journal of Environmental Research and Public Health.</em></li>
 </ol>
 </div>
</div>

<script>
 document.querySelectorAll('.reveal-btn').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && answer.classList.contains('answer-text')) {
 const isVisible = answer.style.display === 'block';
 answer.style.display = isVisible ? 'none' : 'block';
 this.textContent = isVisible ? 'Reveal Answer' : 'Hide Answer';
 }
 });
 });
</script>

</body>
</html>